{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T12:13:03Z","timestamp":1780315983137,"version":"3.54.1"},"reference-count":136,"publisher":"VM Media Group sp. z o.o","issue":"2","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"vor","delay-in-days":731,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","oncology-and-radiotherapy.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reports of Practical Oncology &amp; Radiotherapy"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.rpor.2013.07.009","type":"journal-article","created":{"date-parts":[[2013,8,13]],"date-time":"2013-08-13T19:15:32Z","timestamp":1376421332000},"page":"77-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["The current management of mycosis fungoides and S\u00e9zary syndrome and the role of radiotherapy: Principles and indications"],"prefix":"10.5603","volume":"19","author":[{"given":"Ercole","family":"Mazzeo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rubino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Buglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Antognoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano Maria","family":"Magrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bertoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Parmiggiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Bertoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3595","reference":[{"key":"10.1016\/j.rpor.2013.07.009_bib0005","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1056\/NEJMra032810","article-title":"The pathogenesis of mycosis fungoides","volume":"350","author":"Girardi","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpor.2013.07.009_bib0010","series-title":"World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues","author":"Jaffe","year":"2001"},{"key":"10.1016\/j.rpor.2013.07.009_bib0015","first-page":"354","article-title":"EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer","volume":"90","author":"Willemze","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.rpor.2013.07.009_bib0020","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.rpor.2013.07.009_bib0025","series-title":"WHO classification of tumors of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.rpor.2013.07.009_bib0030","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1182\/blood-2008-10-184168","article-title":"Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases","volume":"113","author":"Bradford","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.rpor.2013.07.009_bib0035","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1610-0387.2007.06337.x","article-title":"Cutaneous lymphomas in Germany: an analysis of the Central Cutaneous Lymphoma Registry of the German Society of Dermatology (DDG)","volume":"5","author":"Assaf","year":"2007","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.rpor.2013.07.009_bib0040","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1001\/archderm.143.7.854","article-title":"Incidence of cutaneous T-cell lymphoma in the United States, 1973\u20132002","volume":"143","author":"Criscione","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0045","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1001\/archderm.1994.01690020064010","article-title":"Profound deficiency in normal circulating T cells in erythrodermic cutaneous T-cell lymphoma","volume":"130","author":"Heald","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0050","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/archderm.143.1.45","article-title":"Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts","volume":"143","author":"Huang","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0055","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5070\/D34J11Z5Z7","article-title":"Fatal outcome due to bacterial superinfection of eczema herpeticum in a patient with mycosis fungoides","volume":"14","author":"Mallo-Garcia","year":"2008","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.rpor.2013.07.009_bib0060","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2165\/11532190-000000000-00000","article-title":"Current and emerging treatment strategies for cutaneous T-cell lymphoma","volume":"70","author":"Lansigan","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.rpor.2013.07.009_bib0065","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1172\/JCI200524826","article-title":"Immunopathogenesis and therapy of cutaneous T cell lymphoma","volume":"115","author":"Kim","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rpor.2013.07.009_bib0070","first-page":"2212","article-title":"Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneious Lymphomas","volume":"95","author":"Vergier","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.rpor.2013.07.009_bib0075","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1182\/blood.V92.4.1150","article-title":"Transformation of mycosis fungoides\/Sezary syndrome: clinical characteristics and prognosis","volume":"92","author":"Diamandidou","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.rpor.2013.07.009_bib0080","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jaad.2005.08.057","article-title":"Defining early mycosis fungoides","volume":"53","author":"Pimpinelli","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0085","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.rpor.2013.07.009_bib0090","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/archderm.142.5.577","article-title":"Staging accuracy in mycosis fungoides and Sezary syndrome using integrated positron emission tomography and computed tomography","volume":"142","author":"Tsai","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0095","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1200\/JCO.2010.32.0630","volume":"29","author":"Olsen","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0100","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1182\/blood-2008-05-154609","article-title":"Long-term outcomes of patients with advanced-stage cutaneous T-cell lymphoma and large cell transformation","volume":"112","author":"Arulogun","year":"2008","journal-title":"Blood"},{"issue":"Suppl. 1","key":"10.1016\/j.rpor.2013.07.009_bib0105","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1111\/j.1440-0960.1997.tb01018.x","article-title":"Mycosis fungoides: an Australian experience","volume":"38","author":"Yen","year":"1997","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0110","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","article-title":"Survival outcomes and prognostic factors in mycosis fungoides\/Sezary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal","volume":"28","author":"Agar","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0115","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/archderm.139.7.857","article-title":"Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression","volume":"139","author":"Kim","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0120","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1001\/archderm.136.4.504","article-title":"Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients","volume":"136","author":"van Doorn","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0125","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0190-9622(99)70491-3","article-title":"Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients","volume":"40","author":"Zackheim","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0130","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1182\/blood.V88.7.2385.bloodjournal8872385","article-title":"Mycosis fungoides and Sezary syndrome","volume":"88","author":"Diamandidou","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.rpor.2013.07.009_bib0135","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1056\/NEJM198912283212603","article-title":"A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides","volume":"321","author":"Kaye","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpor.2013.07.009_bib0140","first-page":"18","article-title":"Choices in the treatment of cutaneous T-cell lymphoma","volume":"21","author":"Hymes","year":"2007","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.rpor.2013.07.009_bib0145","first-page":"513","article-title":"Primary cutaneous T-cell lymphomas","volume":"323\u2013330","author":"Rosen","year":"2006","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.rpor.2013.07.009_bib0150","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1396-0296.2003.01639.x","article-title":"Treatment of patch-stage mycosis fungoides with topical corticosteroids","volume":"16","author":"Zackheim","year":"2003","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.rpor.2013.07.009_bib0155","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/archderm.134.8.949","article-title":"Topical corticosteroids for mycosis fungoides. Experience in 79 patients","volume":"134","author":"Zackheim","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0160","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1396-0296.2003.01641.x","article-title":"Topical carmustine (BCNU) in the treatment of mycosis fungoides","volume":"16","author":"Zackheim","year":"2003","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.rpor.2013.07.009_bib0165","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1396-0296.2003.01640.x","article-title":"Management with topical nitrogen mustard in mycosis fungoides","volume":"16","author":"Kim","year":"2003","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.rpor.2013.07.009_bib0170","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S0190-9622(89)70051-7","article-title":"Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphoma","volume":"20","author":"Vonderheid","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0175","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1001\/archderm.138.3.325","article-title":"Phase 1 and 2 trial of bexarotene gel for skin-directed treatment of patients with cutaneous T-cell lymphoma","volume":"138","author":"Breneman","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0180","first-page":"391","article-title":"Topical imiquimod as treatment for different kinds of cutaneous lymphoma","volume":"16","author":"Coors","year":"2006","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0185","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jaad.2004.04.049","article-title":"Treatment of patch and plaque stage mycosis fungoides with imiquimod 5% cream","volume":"52","author":"Deeths","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0190","first-page":"148","article-title":"Imiquimod in mycosis fungoides","volume":"18","author":"Martinez-Gonzalez","year":"2008","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0195","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1067\/mjd.2003.80","article-title":"Narrowband UVB and psoralen-UVA in the treatment of early-stage mycosis fungoides: a retrospective study","volume":"48","author":"Diederen","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0200","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1001\/archderm.141.3.305","article-title":"Long-term follow-up of patients with early-stage cutaneous T-cell lymphoma who achieved complete remission with psoralen plus UV-A monotherapy","volume":"141","author":"Querfeld","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0205","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1468-3083.2009.03500.x","article-title":"Efficacy of narrowband UVB vs. PUVA in patients with early-stage mycosis fungoides","volume":"24","author":"Ponte","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0210","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1067\/mjd.2002.120911","article-title":"Narrowband UVB phototherapy for early-stage mycosis fungoides","volume":"47","author":"Gathers","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0215","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1396-0296.2003.01643.x","article-title":"Interferon in the treatment of cutaneous T-cell lymphoma","volume":"16","author":"Olsen","year":"2003","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.rpor.2013.07.009_bib0220","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/jnci\/82.3.208","article-title":"Phase II study of recombinant human interferon gamma for treatment of cutaneous T-cell lymphoma","volume":"82","author":"Kaplan","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.rpor.2013.07.009_bib0225","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1200\/JCO.1995.13.1.257","article-title":"Effectiveness of interferon alfa-2a combined with phototherapy for mycosis fungoides and the Sezary syndrome","volume":"13","author":"Kuzel","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0230","first-page":"3578","article-title":"Prospective randomized multicenter clinical trial on the use of interferon \u22122a plus acitretin versus interferon \u22122a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II","volume":"92","author":"Stadler","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.rpor.2013.07.009_bib0235","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1529-8019.2006.00083.x","article-title":"Treatment of cutaneous T-cell lymphoma with retinoids","volume":"19","author":"Zhang","year":"2006","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.rpor.2013.07.009_bib0240","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1200\/JCO.2001.19.9.2456","article-title":"Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II\u2013III trial results","volume":"19","author":"Duvic","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0245","first-page":"581","article-title":"Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma","volume":"137","author":"Duvic","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0250","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1182\/blood-2006-06-025999","article-title":"Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)","volume":"109","author":"Duvic","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.rpor.2013.07.009_bib0255","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1200\/JCO.2006.10.2434","article-title":"Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma","volume":"25","author":"Olsen","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0260","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1200\/JCO.2001.19.2.376","article-title":"Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma","volume":"19","author":"Olsen","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0265","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1200\/JCO.2009.26.2386","article-title":"Phase III placebo-controlled trial of denileukin diftitox for patients with cutaneous T-cell lymphoma","volume":"28","author":"Prince","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0270","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0190-9622(96)80062-4","article-title":"Low-dose methotrexate to treat erythrodermic cutaneous T-cell lymphoma: results in twenty-nine patients","volume":"34","author":"Zackheim","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0275","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0190-9622(03)01591-3","article-title":"Low-dose methotrexate to treat mycosis fungoides: a retrospective study in 69 patients","volume":"49","author":"Zackheim","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0280","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1089\/cbr.2007.0402","article-title":"Interferon and low dose methotrexate improve outcome in refractory mycosis fungoides\/Sezary syndrome","volume":"22","author":"Aviles","year":"2007","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.rpor.2013.07.009_bib0285","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/annonc\/mdp508","article-title":"Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome","volume":"21","author":"Zinzani","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0290","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3816\/CLM.2006.n.039","article-title":"Phase II evaluation of gemcitabine monotherapy for cutaneous T-cell lymphoma","volume":"7","author":"Duvic","year":"2006","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.1016\/j.rpor.2013.07.009_bib0295","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1200\/JCO.2000.18.13.2603","article-title":"Gemcitabine treatment in pretreated cutaneous T-cell lymphoma: experience in 44 patients","volume":"18","author":"Zinzani","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0300","first-page":"1283","article-title":"Phase II trial of temozolomide in patients with pretreated cutaneous T-cell lymphoma","volume":"90","author":"Tani","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.rpor.2013.07.009_bib0305","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1200\/JCO.2007.11.4207","article-title":"Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma","volume":"25","author":"Zinzani","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0310","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/cncr.11593","article-title":"Multicenter study of pegylated liposomal doxorubicin in patients with cutaneous T-cell lymphoma","volume":"98","author":"Wollina","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.rpor.2013.07.009_bib0315","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1200\/JCO.2010.29.9024","article-title":"Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study","volume":"29","author":"O\u2019Connor","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0320","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1056\/NEJM198702053160603","article-title":"Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results","volume":"316","author":"Edelson","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpor.2013.07.009_bib0325","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1396-0296.2003.01646.x","article-title":"The treatment of cutaneous T-cell lymphoma with photopheresis","volume":"16","author":"Zic","year":"2003","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.rpor.2013.07.009_bib0330","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/path.1700640403","article-title":"The sensitivity of lymphocytes to ionising radiation","volume":"64","author":"Trowell","year":"1952","journal-title":"J Pathol Bacteriol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0335","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/0014-2964(77)90107-4","article-title":"Blood and bone marrow response following total body irradiation in patients with lymphosarcomas","volume":"13","author":"Qasim","year":"1977","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.rpor.2013.07.009_bib0340","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1396-0296.2003.01647.x","article-title":"Mycosis fungoides: radiation therapy","volume":"16","author":"Hoppe","year":"2003","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.rpor.2013.07.009_bib0345","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/BF01930916","article-title":"Ueber den einfluss der rontgenstrahlen auf die haut in gesunden und krankem zustande","volume":"59","author":"Scholtz","year":"1902","journal-title":"Arch Dermat U Syph"},{"key":"10.1016\/j.rpor.2013.07.009_bib0350","first-page":"1","article-title":"Mycosis fungoides, and its treatment by the X-rays","volume":"15","author":"Jamieson","year":"1903","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0355","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/00000441-190308000-00014","article-title":"A case of mycosis fungoides symptomatically cured by means of X-rays","volume":"126","author":"Marsh","year":"1903","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.rpor.2013.07.009_bib0360","first-page":"73","article-title":"A case of mycosis fungoides treated by the X-ray","volume":"22","author":"Carrier","year":"1904","journal-title":"J Cutaneous Dis"},{"key":"10.1016\/j.rpor.2013.07.009_bib0365","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1148\/119.2.439","article-title":"Dose-time fractionation study in patients with mycosis fungoides and lymphoma cutis","volume":"119","author":"Kim","year":"1976","journal-title":"Radiology"},{"key":"10.1016\/j.rpor.2013.07.009_bib0370","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/0360-3016(83)90321-8","article-title":"Palliative radiation treatment of cutaneous mycosis fungoides \u2013 a dose response","volume":"9","author":"Cotter","year":"1983","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.rpor.2013.07.009_bib0375","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1365-2133.2011.10728.x","article-title":"Radiation therapy in the management of unilesional primary cutaneous T-cell lymphomas","volume":"166","author":"Chan","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0380","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/09546630802516571","article-title":"Minimal stage IA mycosis fungoides. Results of radiotherapy in 15 patients","volume":"20","author":"Piccinno","year":"2009","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.rpor.2013.07.009_bib0385","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0360-3016(98)00218-1","article-title":"Radiotherapy for unilesional mycosis fungoides","volume":"42","author":"Micaily","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.rpor.2013.07.009_bib0390","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0360-3016(97)00553-1","article-title":"Local superficial radiotherapy in the management of minimal stage IA cutaneous T-cell lymphoma (mycosis fungoides)","volume":"40","author":"Wilson","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.rpor.2013.07.009_bib0395","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0190-9622(89)70008-6","article-title":"Unilesional mycosis fungoides: a distinct entity","volume":"20","author":"Oliver","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0400","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0190-9622(00)90140-3","article-title":"Unilesional cutaneous T-cell lymphoma: clinical features, therapy, and follow-up of 10 patients with a treatment-responsive mycosis fungoides variant","volume":"42","author":"Heald","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0405","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000051542","article-title":"Unilesional mycosis fungoides: a study of seven cases","volume":"201","author":"Hodak","year":"2000","journal-title":"Dermatology"},{"key":"10.1016\/j.rpor.2013.07.009_bib0410","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1365-2230.2002.01044.x","article-title":"Case 4: pagetoid reticulosis (Woringer\u2013Kolopp type) or unilesional mycosis fungoides (MF)","volume":"27","author":"Palmer","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0415","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1346-8138.2003.tb00409.x","article-title":"Unilesional mycosis fungoides mimicking Bowen's disease","volume":"30","author":"Yoo","year":"2003","journal-title":"J Dermatol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0420","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.0736-8046.2004.21507.x","article-title":"Unilesional (segmental) mycosis fungoides presenting in childhood","volume":"21","author":"Alsaleh","year":"2004","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0425","first-page":"1","article-title":"Cutaneous lymphomas \u2013 radiotherapeutic strategies","volume":"39","author":"Wilson","year":"2006","journal-title":"Front Radiat Ther Oncol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0430","series-title":"Non-Hodgikin's Lymphomas, Version 1.2013","author":"NCCN Clinical Practice Guidelines in Oncology","year":"2013"},{"key":"10.1016\/j.rpor.2013.07.009_bib0435","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/archderm.136.8.1007","article-title":"Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma. The New Hampshire Skin Cancer Study Group","volume":"136","author":"Lichter","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0440","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1158\/1078-0432.CCR-09-2879","article-title":"Transcriptional profiles predict disease outcome in patients with cutaneous T-cell lymphoma","volume":"16","author":"Litvinov","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.rpor.2013.07.009_bib0445","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ctrv.2006.08.006","article-title":"Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphoma","volume":"33","author":"Whittaker","year":"2007","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.rpor.2013.07.009_bib0450","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.clon.2012.02.007","article-title":"Skin lymphoma","volume":"24","author":"Morris","year":"2012","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.rpor.2013.07.009_bib0455","series-title":"Radiotherapy and phototherapy","first-page":"257","author":"Allen","year":"1904"},{"key":"10.1016\/j.rpor.2013.07.009_bib0460","first-page":"323","article-title":"Mycosis fungoides treated with general X-ray bath","volume":"51","author":"Sommeroille","year":"1939","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0465","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1148\/74.4.633","article-title":"A technique for large-field, superficial electron therapy","volume":"74","author":"Karzmark","year":"1960","journal-title":"Radiology"},{"key":"10.1016\/j.rpor.2013.07.009_bib0470","first-page":"623","article-title":"High energy electrons for the treatment of extensive superficial malignant lesions","volume":"69","author":"Trump","year":"1953","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"key":"10.1016\/j.rpor.2013.07.009_bib0475","series-title":"Review of radiation oncology physics: a handbook for teachers and students","author":"Podgorsak","year":"2003"},{"key":"10.1016\/j.rpor.2013.07.009_bib0480","series-title":"AAPM report No. 23, total skin electron therapy: technique and dosimetry. Report of group 30 radiation therapy committee AAPM","author":"Karzmack","year":"1987"},{"key":"10.1016\/j.rpor.2013.07.009_bib0485","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejmp.2010.09.001","article-title":"Clinical implementation of total skin electron beam (TSEB) therapy: a review of the relevant literature","volume":"27","author":"Diamantopoulos","year":"2011","journal-title":"Phys Med"},{"key":"10.1016\/j.rpor.2013.07.009_bib0490","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1148\/94.3.635","article-title":"Patient dosimetry in the electron treatment of large superficial lesions","volume":"94","author":"Page","year":"1970","journal-title":"Radiology"},{"key":"10.1016\/j.rpor.2013.07.009_bib0495","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0360-3016(77)90090-6","article-title":"Analysis of dose distributions in whole body superficial electron therapy","volume":"2","author":"Bjarngard","year":"1977","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.rpor.2013.07.009_bib0500","first-page":"625","article-title":"Radiation therapy in the management of cutaneous T-cell lymphomas","volume":"63","author":"Hoppe","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.rpor.2013.07.009_bib0505","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1120\/jacmp.v9i4.2793","article-title":"Rotational total skin electron irradiation with a linear accelerator","volume":"9","author":"Reynard","year":"2008","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.rpor.2013.07.009_bib0510","first-page":"308","article-title":"Palliative total skin electron beam therapy (TSEBT) for advanced cutaneous T-cell lymphoma","volume":"18","author":"Funk","year":"2008","journal-title":"Eur J Dermatol"},{"issue":"1","key":"10.1016\/j.rpor.2013.07.009_bib0515","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1507-1367(06)71047-1","article-title":"The rotary dual technique for total skin irradiation in the treatment of mycosis fungoides \u2013 a description of the applied method","volume":"11","author":"Piotrowski","year":"2006","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.rpor.2013.07.009_bib0520","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1259\/0007-1285-52-616-302","article-title":"Whole body electron therapy in mycosis fungoides \u2013 a successful translational technique achieved by modification of an established linear accelerator","volume":"52","author":"Williams","year":"1979","journal-title":"Br J Radiol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0525","first-page":"392","article-title":"Total-skin electron irradiation for cutaneous T-cell lymphoma: the Northern Israel Oncology Center experience","volume":"167","author":"Kuten","year":"1991","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0530","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/10428199809050937","article-title":"Total skin electron irradiation in mycosis fungoides dose and fractionation considerations","volume":"30","author":"Rosenblatt","year":"1998","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.rpor.2013.07.009_bib0535","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1080\/1042819021000016177","article-title":"Total skin electron irradiation in mycosis fungoides: comparison between a modified Christie Hospital translational technique and the Stanford technique","volume":"43","author":"Anacak","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.rpor.2013.07.009_bib0540","first-page":"202","article-title":"Total skin electron therapy: a modified technique for small room linear accelerator","volume":"16","author":"Shouman","year":"2004","journal-title":"J Egypt Natl Cancer Inst"},{"key":"10.1016\/j.rpor.2013.07.009_bib0545","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.ijrobp.2004.02.046","article-title":"Matching the dosimetry characteristics of a dual-field Stanford technique to a customized single-field Stanford technique for total skin electron therapy","volume":"59","author":"Chen","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.rpor.2013.07.009_bib0550","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0167-8140(92)90374-4","article-title":"Clinical experience with a single field rotational total skin electron irradiation technique for cutaneous T-cell lymphoma","volume":"24","author":"Freeman","year":"1992","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0555","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4103\/0971-6203.49854","article-title":"Clinical electron beam configuration and physical parameters for total skin electron treatment (Test)","volume":"30","author":"Ravichandran","year":"2005","journal-title":"J Med Phys"},{"key":"10.1016\/j.rpor.2013.07.009_bib0560","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0360-3016(77)90182-1","article-title":"The rationale for curative radiotherapy in mycosis fungoides","volume":"2","author":"Hoppe","year":"1977","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.rpor.2013.07.009_bib0565","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1067\/mjd.2002.123482","article-title":"Total skin electron radiation in the management of mycosis fungoides: consensus of the European Organization for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Project Group","volume":"47","author":"Jones","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0570","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1148\/radiology.176.2.2367660","article-title":"In vivo high-resolution MR imaging of the skin in a whole-body system at 1.5T","volume":"176","author":"Bittoun","year":"1990","journal-title":"Radiology"},{"key":"10.1016\/j.rpor.2013.07.009_bib0575","series-title":"Phantoms and computational models in therapy, diagnosis and protection","year":"1993"},{"key":"10.1016\/j.rpor.2013.07.009_bib0580","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0889-8588(18)30058-3","article-title":"Electron beam treatment for cutaneous T-cell lymphoma","volume":"9","author":"Jones","year":"1995","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.rpor.2013.07.009_bib0585","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0360-3016(86)90361-5","article-title":"Dose distribution in total skin electron beam irradiation using the six-field technique","volume":"12","author":"Niroomand-Rad","year":"1986","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.rpor.2013.07.009_bib0590","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0009-9260(82)80156-6","article-title":"Comparison of dose distribution with different techniques of total skin electron beam therapy","volume":"33","author":"Kumar","year":"1982","journal-title":"Clin Radiol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0595","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0360-3016(88)90306-9","article-title":"Total skin electron irradiation for mycosis fungoides: relationship between acute toxicities and measured dose at different anatomic sites","volume":"15","author":"Desai","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.rpor.2013.07.009_bib0600","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0360-3016(97)00585-3","article-title":"Utilization of thermoluminescent dosimetry in total skin electron beam radiotherapy of mycosis fungoides","volume":"40","author":"Antolak","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.rpor.2013.07.009_bib0605","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1001\/archderm.139.6.812","article-title":"Delivery and sequelae of total skin electron beam therapy","volume":"139","author":"Wilson","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0610","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/COC.0b013e3181841f5c","article-title":"Patient perspectives regarding the value of total skin electron beam therapy for cutaneous T-cell lymphoma\/mycosis fungoides: a pilot study","volume":"32","author":"Yu","year":"2009","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0615","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.ijrobp.2003.08.007","article-title":"Ultimate results of radiation therapy for T1\u2013T2 mycosis fungoides (including reirradiation)","volume":"58","author":"Ysebaert","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.rpor.2013.07.009_bib0620","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.semradonc.2007.02.001","article-title":"Cutaneous lymphomas","volume":"17","author":"Smith","year":"2007","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0625","first-page":"1985","article-title":"Total skin electron radiation for patients with erythrodermic cutaneous T-cell lymphoma (mycosis fungoides and the Sezary syndrome)","volume":"85","author":"Jones","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.rpor.2013.07.009_bib0630","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archdermatol.2011.98","article-title":"The Stanford University experience with conventional-dose, total skin electron-beam therapy in the treatment of generalized patch or plaque (T2) and tumor (T3) mycosis fungoides","volume":"147","author":"Navi","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0635","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jaad.2007.12.016","article-title":"Total skin electron beam therapy may be associated with improvement of peripheral blood disease in Sezary syndrome","volume":"58","author":"Introcaso","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0640","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1748-717X-7-118","article-title":"Total skin electron beam therapy as palliative treatment for cutaneous manifestations of advanced, therapy-refractory cutaneous lymphoma and leukemia","volume":"7","author":"Hauswald","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0645","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0190-9622(96)90499-5","article-title":"Additional courses of total skin electron beam therapy in the treatment of patients with recurrent cutaneous T-cell lymphoma","volume":"35","author":"Wilson","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0650","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/0360-3016(94)00590-H","article-title":"Multiple courses of high-dose total skin electron beam therapy in the management of mycosis fungoides","volume":"32","author":"Becker","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.rpor.2013.07.009_bib0655","doi-asserted-by":"crossref","first-page":"e651","DOI":"10.1016\/j.ijrobp.2011.01.023","article-title":"Revisiting low-dose total skin electron beam therapy in mycosis fungoides","volume":"81","author":"Harrison","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.rpor.2013.07.009_bib0660","unstructured":"Kim Y. Low dose (12Gy) TSEB + Vorinostat versus low-dose TSEB monotherapy in mycosis fungoides. 2013, NCT01187446."},{"key":"10.1016\/j.rpor.2013.07.009_bib0665","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0360-3016(97)00127-2","article-title":"Total skin electron beam therapy followed by adjuvant psoralen\/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides)","volume":"38","author":"Quiros","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.rpor.2013.07.009_bib0670","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0360-3016(98)00517-3","article-title":"Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides","volume":"43","author":"Chinn","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.rpor.2013.07.009_bib0675","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1200\/JCO.2009.25.8301","article-title":"Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sezary syndrome","volume":"28","author":"Duvic","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rpor.2013.07.009_bib0680","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.1259\/bjr\/61338036","article-title":"Total scalp radiation using image-guided IMRT for progressive cutaneous T cell lymphoma","volume":"82","author":"Samant","year":"2009","journal-title":"Br J Radiol"}],"container-title":["Reports of Practical Oncology &amp; Radiotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1507136713010146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1507136713010146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T13:18:11Z","timestamp":1715865491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1507136713010146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":136,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S1507136713010146"],"URL":"https:\/\/doi.org\/10.1016\/j.rpor.2013.07.009","relation":{},"ISSN":["1507-1367"],"issn-type":[{"value":"1507-1367","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The current management of mycosis fungoides and S\u00e9zary syndrome and the role of radiotherapy: Principles and indications","name":"articletitle","label":"Article Title"},{"value":"Reports of Practical Oncology & Radiotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpor.2013.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Greater Poland Cancer Centre. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}